Suppr超能文献

[钙敏感受体拮抗剂。JTT - 305/MK - 5442]

[Antagonist for calcium-sensing receptor. JTT-305/MK-5442].

作者信息

Fukumoto Seiji

机构信息

Division of Nephrology & Endocrinology, Department of Medicine, University of Tokyo Hospital.

出版信息

Clin Calcium. 2011 Jan;21(1):89-93.

Abstract

Calcium-sensing receptor (CaSR) is a G protein-coupled receptor which was identified as a molecule that medicates the suppression of parathyroid hormone (PTH) secretion by extracellular Ca. Calcilytics are chemicals that enhance PTH secretion by antagonizing CaSR. JTT-305/MK-5442 is one of calcilytics made in Japan and is considered to be used as a bone anabolic agent through its stimulatory effect on PTH secretion. It is reported that JTT-305/MK-5442 increased lumbar bone mineral density by a placebo-controlled trial. However, further studies with more subjects are necessary to establish the clinical utility of JTT-305/MK-5442.

摘要

钙敏感受体(CaSR)是一种G蛋白偶联受体,它被确定为一种介导细胞外钙抑制甲状旁腺激素(PTH)分泌的分子。钙增敏剂是通过拮抗CaSR来增强PTH分泌的化学物质。JTT-305/MK-5442是日本生产的一种钙增敏剂,通过其对PTH分泌的刺激作用,被认为可作为一种骨合成代谢剂。一项安慰剂对照试验报告称,JTT-305/MK-5442可提高腰椎骨密度。然而,需要更多受试者进行进一步研究,以确定JTT-305/MK-5442的临床应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验